Compass Therapeutics to Participate in Upcoming December Investor Events

Rhea-AI Summary

Compass Therapeutics (Nasdaq: CMPX) will participate in two investor events in December 2025: the Piper Sandler 37th Annual Healthcare Conference in New York on Dec 2, 2025 at 8:00 AM ET and the Evercore 8th Annual Healthcare Conference in Coral Gables on Dec 4, 2025 at 10:00 AM ET.

Live webcasts are provided for each presentation and recordings will be archived for 90 days on Compass’ Events page. Management will be available for one-on-one meetings during both events; interested investors should contact their representatives to request meetings.

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of December.

Details are as follows:

Piper Sandler 37^th Annual Healthcare Conference
Location: New York, NY
Date: Tuesday, December 2, 2025
Time: 8:00 AM ET
Webcast Link: https://event.webcasts.com/starthere.jsp?ei=1744426&tp_key=c56d01f519

8^th Annual Evercore Healthcare Conference
Location: Coral Gables, FL
Date: Thursday, December 4, 2025
Time: 10:00 AM ET
Webcast Link: https://wsw.com/webcast/evercore52/cmpx/2381104

Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.

Compass’ management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.

About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These pathways include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.

Investor Contact
ir@compasstherapeutics.com 

Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com 
617-500-8099

FAQ

When will Compass Therapeutics (CMPX) present at the Piper Sandler conference in 2025?

Compass will present at the Piper Sandler 37th Annual Healthcare Conference on Dec 2, 2025 at 8:00 AM ET in New York with a live webcast.

What is the date and time for Compass Therapeutics (CMPX) at the Evercore Healthcare Conference?

Compass will present at the 8th Annual Evercore Healthcare Conference on Dec 4, 2025 at 10:00 AM ET in Coral Gables with a live webcast.

Where can I watch the Compass Therapeutics (CMPX) webcasts for the December 2025 events?

Live webcasts are provided via the event links and recordings will be archived for 90 days on Compass’ Events page.

Will Compass Therapeutics (CMPX) offer one-on-one meetings at the December 2025 investor events?

Yes. Compass management will be available for one-on-one meetings during both events; investors should contact their representatives to request meetings.

How long will Compass Therapeutics (CMPX) event presentations be available to replay?

Presentations will be archived and available for replay for 90 days on the company's Events page.

Who should investors contact to arrange a meeting with Compass Therapeutics (CMPX) management at these events?

Interested investors should contact their broker or conference representative to request one-on-one meetings with Compass management.